Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170625
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2005-09-09
Brief Title:
Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer
Sponsor:
North Eastern German Society of Gynaecological Oncology
Organization:
North Eastern German Society of Gynaecological Oncology
Study Overview
Official Title:
Multicenter Prospective Phase-III-study Topotecan and Carboplatin in the Therapy of Patients With Relapsed Ovarian Cancer
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compatibility of the topotecan therapy in combination with carboplatin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None